- Headquarters
- Mainz, Germany · Europe
- Value chain
- Medicines & vaccines(Products); also Research & IP
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 2008
- Staff
- 6,772 (2024)
- Ownership
- Listed
- Listing
- Nasdaq:BNTX on Google Finance
- Website
- biontech.com
- Relevance
- Very high at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Mainz, GermanyIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #10 of 50
Invented the BNT162b2 mRNA COVID-19 vaccine, is developing mRNA cancer immunotherapies, and agreed to acquire CureVac in 2025.
Relevance: Invented BNT162b2 mRNA vaccine